Abstract:The present study was designed to investigate the tumor inhibitory potential of bryostatin 1 in a 12‑O‑tetradecanoylphorbol‑13‑acetate (TPA)‑induced mouse model of skin cancer. The radical inhibition potential of various doses of bryostatin 1 was investigated against 2,2‑diphenyl‑1‑picrylhydrazyl (DPPH) bleach in vitro. The DPPH radical potential was observed compared with treatment with 5, 10, 15, 20, 25 and 30 µM doses of bryostatin 1. In vivo, bryostatin 1 prevented the TPA‑mediated increase in the level of H2O2 and myeloperoxidase in mouse epidermal tissue. Pretreatment of the mice with bryostatin 1 (30 µM) followed by administration of TPA reduced the edema, as demonstrated via punched‑out mouse ear tissue, to 7.2 mg, compared with 14 mg in the TPA‑treated group. Treatment with bryostatin 1 prior to TPA administration markedly prevented the inflammation of the skin by inhibiting hyperplasia in the epidermal layer and the aggregation of inflammatory cells. The results demonstrated that treatment of mice with bryostatin 1 at a 30 µM dose prior to TPA administration significantly (P<0.005) inhibited the TPA‑mediated increase in the level of COX‑2. The activity of ornithine decarboxylase, increased by TPA, was additionally inhibited following pretreatment of the mice with bryostatin 1. In the mice treated with bryostatin 1 at 30 µM doses prior to the administration of TPA, the appearance of papillomas was 20%, compared with 100% in the TPA group. Mice pretreated with bryostatin 1 at 30 µM doses prior to TPA administration exhibited the appearance of 0.4 mean papillomas in each animal, compared with 5.2 in the TPA group. Therefore, the results of the present study demonstrated that bryostatin 1 inhibited the development and progression of tumors of skin in the mice, through the prevention of inflammation‑inducing processes and the quenching of radicals. Therefore, bryostatin 1 maybe considered to be adrug of importance in the treatment of skin tumor.

Tumor Promoter TPA Activates Wnt/β-catenin Signaling in a Casein Kinase 1-Dependent Manner.

REGγ is Critical for Skin Carcinogenesis by Modulating the Wnt/β-catenin Pathway

Hair follicle stem cell proliferation, Akt and Wnt signaling activation in TPA-induced hair regeneration

12-O-tetradecanoylphorbol-13-acetate Activates Hair Follicle Melanocytes for Hair Pigmentation Via Wnt/β-catenin Signaling

Lgr4 is Crucial for Skin Carcinogenesis by Regulating MEK/ERK and Wnt/β-catenin Signaling Pathways

Modulation Of Beta-Catenin Signaling By The Inhibitors Of Map Kinase, Tyrosine Kinase, And Pi3-Kinase Pathways

Original Protein tyrosine phosphatase PTPN2 regulates TGF- signaling through Smad4 dephosphorylation

Tumor promotion by depleting cells of protein kinase C delta.

PTPN3 Acts As a Tumor Suppressor and Boosts TGF-β Signaling Independent of Its Phosphatase Activity.

P2RY6 Has a Critical Role in Mouse Skin Carcinogenesis by Regulating the YAP and β-Catenin Signaling Pathways.

TPA stimulates the synthesis of alpha(5)beta(1) integrin.

Wnt-independent Beta-Catenin Transactivation in Tumor Development.

DNA Methylome and Transcriptome Study of Triterpenoid CDDO in TPA-Mediated Skin Carcinogenesis Model

Phosphorylated PTTG1 switches its subcellular distribution and promotes β-catenin stabilization and subsequent transcription activity

12-O-Tetradecanoylphorbol-13-acetate (TPA) is anti-tumorigenic in liver cancer cells via inhibiting YAP through AMOT

TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.

Bryostatin 1 Causes Attenuation of TPA‑mediated Tumor Promotion in Mouse Skin.

Usp1-Wdr48 Deubiquitinase Complex Enhances Tgf-Beta Induced Epithelial-Mesenchymal Transition Of Tnbc Cells Via Stabilizing Tak1

tPA promotes the proliferation of lung fibroblasts and activates the Wnt/β-catenin signaling pathway in idiopathic pulmonary fibrosis.

Chronic Exposure to 12-O-tetradecanoylphorbol-13-acetate Represses Sod2 Induction in Vivo: the Negative Role of P50

TWEAK Promotes the Proliferation of Squamous Cell Carcinoma Cells Through Activating Ciap1 Signals